3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
12
Recruiting
8
Unknown
7
Active not recruiting
6
Terminated
4
Not yet recruiting
3
Suspended
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Clinical Stage I Gastric Cancer AJCC v8
1
Interventions
Cisplatin
9
Standard of Care
6
Educational Status
6
Nivolumab
5
Interviews as Topic
5
Carboplatin
5
Radiotherapy
4
Paclitaxel
4
Oxaliplatin
4
Fluorodeoxyglucose F18
4
Dexamethasone
4
pembrolizumab
3
camrelizumab
3
Practice Guidelines as Topic
3
Patient Navigation
3
Methods
3
Magnetic Resonance Spectroscopy
3
Magnetic Resonance Imaging
3
Lenalidomide
3
Fluorouracil
3
Exercise
3
Early Intervention, Educational
3
Drug Therapy
3
Cytarabine
3
130-nm albumin-bound paclitaxel
3
venetoclax
2
toripalimab
2
tislelizumab
2
sacituzumab govitecan
2
lenvatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Interventional
×
Lymph Node Excision
×
Clear all
NCT07139951
2025-12-31
HORIZON
Mayo Clinic
Phase 2
Enrolling by invitation
16 enrolled